GHRP-2 and GHRP-6 are both Growth Hormone Secretagogues (GHSs) that stimulate the release of endogenous growth hormone (GH). Evidence suggests they act by binding to the ghrelin receptor, thereby influencing the body's neuroendocrine axes. The primary use case supported by the indexed studies for both peptides is related to their ability to modulate GH release, with implications for conditions associated with GH deficiency or catabolic states. GHRP-2 has been studied for its potential in treating GH deficiency even in individuals with co-existing hypogonadism and in postmenopausal women, where estradiol replacement amplified its GH-releasing effect. GHRP-6 has been explored for its clinical potential in GH modulation and is frequently mentioned in the context of anti-doping efforts due to its misuse in sports.
| GHRP-2 | GHRP-6 | |
|---|---|---|
| Drug class | ghrelin mimetic | ghrelin mimetic |
| Studies in corpus | 92 | 107 |
| Highest evidence tier | rct | rct |
| Evidence tier mix | review · 11 other · 43 preclinical animal · 18 rct · 7 case report · 5 case series · 1 in vitro · 7 | preclinical animal · 67 other · 14 in vitro · 18 rct · 1 review · 5 |
| Studies with explicit sample size | 6 | 1 |
| Head-to-head studies in corpus | 11 | |
Beyond the literature: here's what third-party Certificate-of-Analysis records (Janoshik, BCC, Auxlabs) say about real GHRP-2 and GHRP-6 batches we've tested. Aggregate, public data — cross-reference against the studies below.
We tested 72 GHRP-2 batches across 46 manufacturers, 99.3% avg purity.
We tested 101 GHRP-6 batches across 65 manufacturers, 99.5% avg purity.
We hold deeper lab coverage on GHRP-6 (101 batches tested). GHRP-6 edges ahead on average measured purity (99.3% vs 99.5%) — a narrow gap; weigh it against failed-batch and underdose counts above.
Studies in our corpus that mention both GHRP-2 and GHRP-6 — the gold-standard direct comparison evidence.
The discovery of ghrelin fundamentally transformed our understanding of growth hormone regulation, appetite control, and energy balance. It revealed a novel endocrine system linking the gut directly to the brain's neuroendocrine axes, providing critical ins…
The development of GHSs represents a paradigm shift in treating conditions associated with GH deficiency or catabolic states. These compounds offer a non-invasive, orally active alternative to recombinant GH, potentially expanding access to anabolic therapi…
This advanced analytical method provides a crucial tool for anti-doping agencies to combat the illicit use of GHRPs in both equine and human sports. By enabling reliable and high-throughput detection, it helps ensure fair competition and protects athlete he…
This research establishes a critical direct neuroendocrine link between the ghrelin signaling pathway and the regulation of AVP, a key component of the body's stress response system and fluid homeostasis. Understanding how ghrelin and its mimetics directly …
This research highlights a novel regulatory mechanism for ACTH secretion, involving the interplay between BMP and GHRP signaling pathways. Understanding these interactions is crucial for comprehending the intricate control of the hypothalamic-pituitary-adre…
This research provides crucial analytical standards and degradation profiles that can significantly enhance anti-doping detection capabilities. By understanding how these peptides break down, forensic laboratories can identify not only the intact substance …
This research significantly enhances anti-doping capabilities by providing specific, long-lasting biomarkers for GHRPs administered nasally. The identification of these metabolites means that athletes misusing these substances can be detected for a much lon…
This study provides crucial evidence of the ongoing misuse of GHRP-2 and GHRP-6 in sports and validates a robust analytical method for their detection. The ability to accurately identify these peptides in athlete urine significantly strengthens anti-doping …
Improved and more sensitive detection methods are paramount for maintaining the integrity and fairness of competitive sports. By identifying novel metabolites and optimizing analytical protocols, this research significantly enhances the ability of anti-dopi…
This study provides a highly sensitive and robust analytical tool that significantly enhances the capabilities of anti-doping laboratories to detect GHRP abuse. By simultaneously identifying both parent GHRPs and their metabolites, the method extends the de…
No direct head-to-head trials in our corpus. Indirect comparison only. While both GHRP-2 and GHRP-6 are GHSs, some studies suggest nuances in their physiological effects. For instance, GHRP-2 has been observed not to affect water-regulating hormone (AVP) in healthy men, suggesting it may not cause adverse effects related to fluid retention. However, other preclinical animal studies indicate that ghrelin and GHSs, which would include both GHRP-2 and GHRP-6, can directly boost AVP in rat brain cells, highlighting a potential species or context-dependent difference. GHRP-2 has also shown a significantly greater peak GH concentration in postmenopausal women receiving estradiol replacement compared to placebo. In children with Growth Hormone Deficiency, intranasal GHRP-2 boosted GH but did not spur linear growth, indicating that GH release alone may not be sufficient for growth in this population. Both peptides are frequently mentioned in anti-doping contexts, with advanced analytical methods developed to detect them and their metabolites in athlete urine, even after nasal administration or degradation.
Looking for vendor-level purity, endotoxin, and HPLC data on GHRP-2 or GHRP-6? TitrateLab tracks Certificate-of-Analysis records from the major peptide labs (Janoshik, BCC, Auxlabs) alongside the research above. Cross-reference vendor batches against the studies on this page.